Literature DB >> 23055858

Use of surfactants.

Sunil K Sinha1.   

Abstract

Year:  2007        PMID： 23055858      PMCID： PMC3462089          DOI： 10.5863/1551-6776-12.4.266

Source DB:  PubMed          Journal:  J Pediatr Pharmacol Ther        ISSN： 1551-6776


× No keyword cloud information.
  20 in total

1.  A randomized, multicenter masked comparison trial of poractant alfa (Curosurf) versus beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infants.

Authors:  Rangasamy Ramanathan; Maynard R Rasmussen; Dale R Gerstmann; Neil Finer; Krishnamurthy Sekar
Journal:  Am J Perinatol       Date:  2004-04       Impact factor: 1.862

2.  Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement.

Authors:  Gilda Piaggio; Diana R Elbourne; Douglas G Altman; Stuart J Pocock; Stephen J W Evans
Journal:  JAMA       Date:  2006-03-08       Impact factor: 56.272

Review 3.  Aerosolized surfactants.

Authors:  Jan Mazela; T Allen Merritt; Neil N Finer
Journal:  Curr Opin Pediatr       Date:  2007-04       Impact factor: 2.856

4.  Practical considerations in the selection and use of pulmonary surfactant therapy for neonatal respiratory distress syndrome in the intensive care setting.

Authors:  Karen E Corff; Steve Greubel; Debra L McCann; Richard Williams; Dwight L Varner
Journal:  J Pediatr Pharmacol Ther       Date:  2006-07

5.  Brief report: deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis.

Authors:  L M Nogee; D E de Mello; L P Dehner; H R Colten
Journal:  N Engl J Med       Date:  1993-02-11       Impact factor: 91.245

6.  Comparison of Infasurf (calfactant) and Survanta (beractant) in the prevention and treatment of respiratory distress syndrome.

Authors:  Barry T Bloom; Reese H Clark
Journal:  Pediatrics       Date:  2005-08       Impact factor: 7.124

7.  Surfactant replacement therapy in neonatal respiratory distress syndrome. A multi-centre, randomized clinical trial: comparison of high- versus low-dose of surfactant TA.

Authors:  M Konishi; T Fujiwara; T Naito; Y Takeuchi; Y Ogawa; K Inukai; M Fujimura; H Nakamura; T Hashimoto
Journal:  Eur J Pediatr       Date:  1988-01       Impact factor: 3.183

8.  Synthetic peptide-containing surfactants--evaluation of transmembrane versus amphipathic helices and surfactant protein C poly-valyl to poly-leucyl substitution.

Authors:  G Nilsson; M Gustafsson; G Vandenbussche; E Veldhuizen; W J Griffiths; J Sjövall; H P Haagsman; J M Ruysschaert; B Robertson; T Curstedt; J Johansson
Journal:  Eur J Biochem       Date:  1998-07-01

9.  Pulmonary surfactant protein B (SP-B): structure-function relationships.

Authors:  C G Cochrane; S D Revak
Journal:  Science       Date:  1991-10-25       Impact factor: 47.728

10.  Surfactants in the management of respiratory distress syndrome in extremely premature infants.

Authors:  Rangasamy Ramanathan
Journal:  J Pediatr Pharmacol Ther       Date:  2006-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.